Announcer Han Seok-joon selected a Fluad Quad model for the elderly's immuno-enhanced influenza vaccine
Sep 19, 2025
|
Global vaccine companies CSL Sequirus Korea and Samjin Pharmaceutical have selected announcer Han Seok-joon, who gives trust to the public, as a model and announced that they will conduct a new advertising campaign for the immuno-enhanced influenza vaccine for the elderly aged 65 and over.
This campaign increased friendliness by utilizing the nickname 'Ad', which was conceived from the product name 'Fluadquad'. In particular, the focus was on ensuring that the elderly over 65 years of age recognize the Fluard Quad as a reliable partner in life.
Influenza has the highest risk of severe illness, such as hospitalization and death, in the elderly over 65 years of age. In fact, it is estimated that about 70% of hospitalized patients and 90% of deaths due to influenza occur in the elderly. In particular, it has been confirmed that the elderly infected with influenza have a 3-5 times higher risk of heart attack and a 2-3 times higher risk of stroke in the first two weeks, and the risk of death is known to increase by up to 6 times. However, due to the decline in immune function due to aging, the preventive effect remains at the 31-58% level even after standard influenza vaccination, and new alternatives have been steadily required.
Fluadquad, including the immunostimulator MF59, enhances the immune response of the elderly to increase the effectiveness of influenza prevention, and the magnitude and breadth of the immune response have been observed in some studies compared to standard influenza vaccines. This is expected to contribute to more continuous prevention in the elderly by providing long-term protection of up to one year, unlike existing vaccines that usually show preventive effects for about six months. Fluad quad can be inoculated at major hospitals and clinics nationwide this 2025/26 season.
Yoo Ki-seung, CEO of CSL Sequirus Korea, said, `I hope that through this advertising campaign, the Fluad Quad, or 'Ad', will become a strong vaccine to protect the elderly from influenza.'"Korea has already entered a super-aged society, and it is common to have a family structure in which three generations of grandparents, parents, and grandchildren interact closely." Due to this characteristic, the flu transmitted from grandchildren can have fatal consequences for the elderly, which has a great impact on the overall care system and public health beyond the care gap at home. CSL Sequirascoria is a global vaccine company that has stably supplied vaccines to the Korean market, and we will do our best to contribute to the health protection of the elderly and the entire people in Korea and public health safety through effective vaccines such as Fluad Quad with Samjin Pharmaceutical."
"Through this advertising campaign, we hope that the vaccine that is more effective in preventing influenza in the elderly will be recognized as Fluadquad containing immunostimulants," said Samjin Kim"For the upcoming flu season, Samjin Pharmaceutical will do its best to provide a stable supply of high-quality vaccines with CSL Equirascoria, which will actively contribute to the prevention of infection for the health of all people, including the elderly."," he said.
This article was translated by Naver AI translator.
